Organon Other Current Assets vs Accounts Payable Analysis

OGN Stock

USD 14.89 0.16 1.09%

Organon financial indicator trend analysis is much more than just breaking down Organon prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Organon is a good investment. Please check the relationship between Organon Other Current Assets and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Other Current Assets vs Accounts Payable

Other Current Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Organon Other Current Assets account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Organon's Other Current Assets and Accounts Payable is -0.48. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Organon Co, assuming nothing else is changed. The correlation between historical values of Organon's Other Current Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Organon Co are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Other Current Assets i.e., Organon's Other Current Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.48

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Accounts Payable

An accounting item on the balance sheet that represents Organon obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Organon are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Organon's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Organon current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

As of the 22nd of November 2024, Tax Provision is likely to drop to about 90.2 M. In addition to that, Selling General Administrative is likely to drop to about 1.3 B

	2021	2022	2023	2024 (projected)
Interest Expense	258M	422M	527M	553.4M
Tax Provision	178M	205M	95M	90.3M

Interest Expense Tax Provision

Organon fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Accounts Payable	Cash	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Long Term Debt Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Cash And Equivalents	Intangible Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net
Total Assets		0.68	0.45	0.77	-0.59	-0.78	-0.72	0.7	0.67	-0.56	0.68	0.67	0.32	-0.9	0.73	0.84	0.85	-0.37	0.02	0.62	0.93	0.67	-0.66	-0.66	0.75	0.8
Short Long Term Debt Total	0.68		0.47	0.97	-0.83	-0.95	-0.98	0.99	0.94	-0.64	1.0	0.94	-0.02	-0.42	0.31	0.95	0.4	-0.46	-0.06	0.86	0.64	0.95	-0.56	-0.82	0.83	0.84
Other Current Liab	0.45	0.47		0.32	-0.82	-0.66	-0.5	0.45	0.74	-0.94	0.47	0.74	-0.67	-0.38	0.33	0.51	0.21	0.52	0.31	0.81	0.26	0.25	-0.93	-0.83	0.81	0.8
Total Current Liabilities	0.77	0.97	0.32		-0.72	-0.89	-0.94	0.97	0.85	-0.51	0.97	0.85	0.21	-0.5	0.34	0.94	0.55	-0.61	-0.15	0.76	0.74	0.97	-0.45	-0.73	0.77	0.8
Total Stockholder Equity	-0.59	-0.83	-0.82	-0.72		0.9	0.87	-0.82	-0.96	0.94	-0.83	-0.96	0.47	0.45	-0.41	-0.83	-0.19	-0.04	0.09	-0.99	-0.38	-0.62	0.77	1.0	-0.89	-0.94
Other Liab	-0.78	-0.95	-0.66	-0.89	0.9		0.97	-0.94	-0.97	0.79	-0.95	-0.97	0.14	0.61	-0.54	-0.98	-0.45	0.29	-0.09	-0.91	-0.68	-0.85	0.77	0.91	-0.89	-0.93
Net Tangible Assets	-0.72	-0.98	-0.5	-0.94	0.87	0.97		-0.97	-0.94	0.7	-0.98	-0.94	0.06	0.53	-0.47	-0.98	-0.36	0.44	0.13	-0.89	-0.62	-0.89	0.59	0.87	-0.81	-0.87
Accounts Payable	0.7	0.99	0.45	0.97	-0.82	-0.94	-0.97		0.93	-0.63	0.99	0.93	0.01	-0.44	0.32	0.95	0.42	-0.48	-0.08	0.85	0.65	0.95	-0.54	-0.81	0.81	0.84
Cash	0.67	0.94	0.74	0.85	-0.96	-0.97	-0.94	0.93		-0.86	0.94	1.0	-0.31	-0.46	0.38	0.92	0.33	-0.15	0.05	0.97	0.54	0.81	-0.77	-0.95	0.92	0.94
Other Assets	-0.56	-0.64	-0.94	-0.51	0.94	0.79	0.7	-0.63	-0.86		-0.63	-0.86	0.6	0.5	-0.46	-0.69	-0.2	-0.31	-0.1	-0.92	-0.32	-0.41	0.9	0.94	-0.84	-0.9
Long Term Debt	0.68	1.0	0.47	0.97	-0.83	-0.95	-0.98	0.99	0.94	-0.63		0.94	-0.02	-0.42	0.31	0.95	0.4	-0.46	-0.06	0.86	0.64	0.95	-0.55	-0.82	0.83	0.84
Cash And Short Term Investments	0.67	0.94	0.74	0.85	-0.96	-0.97	-0.94	0.93	1.0	-0.86	0.94		-0.31	-0.46	0.38	0.92	0.33	-0.15	0.05	0.97	0.54	0.81	-0.77	-0.95	0.92	0.94
Net Receivables	0.32	-0.02	-0.67	0.21	0.47	0.14	0.06	0.01	-0.31	0.6	-0.02	-0.31		-0.27	0.13	0.05	0.57	-0.76	-0.19	-0.42	0.5	0.23	0.44	0.42	-0.24	-0.24
Good Will	-0.9	-0.42	-0.38	-0.5	0.45	0.61	0.53	-0.44	-0.46	0.5	-0.42	-0.46	-0.27		-0.93	-0.68	-0.7	0.26	-0.02	-0.44	-0.78	-0.37	0.6	0.52	-0.5	-0.63
Common Stock Shares Outstanding	0.73	0.31	0.33	0.34	-0.41	-0.54	-0.47	0.32	0.38	-0.46	0.31	0.38	0.13	-0.93		0.6	0.43	-0.22	0.01	0.36	0.57	0.22	-0.53	-0.47	0.35	0.5
Long Term Debt Total	0.84	0.95	0.51	0.94	-0.83	-0.98	-0.98	0.95	0.92	-0.69	0.95	0.92	0.05	-0.68	0.6		0.52	-0.46	-0.04	0.84	0.75	0.88	-0.65	-0.85	0.82	0.89
Inventory	0.85	0.4	0.21	0.55	-0.19	-0.45	-0.36	0.42	0.33	-0.2	0.4	0.33	0.57	-0.7	0.43	0.52		-0.34	0.22	0.26	0.94	0.52	-0.44	-0.27	0.53	0.5
Other Current Assets	-0.37	-0.46	0.52	-0.61	-0.04	0.29	0.44	-0.48	-0.15	-0.31	-0.46	-0.15	-0.76	0.26	-0.22	-0.46	-0.34		0.31	0.01	-0.5	-0.63	-0.31	-0.03	0.01	-0.05
Other Stockholder Equity	0.02	-0.06	0.31	-0.15	0.09	-0.09	0.13	-0.08	0.05	-0.1	-0.06	0.05	-0.19	-0.02	0.01	-0.04	0.22	0.31		-0.08	0.22	0.02	-0.47	0.08	0.08	-0.02
Total Liab	0.62	0.86	0.81	0.76	-0.99	-0.91	-0.89	0.85	0.97	-0.92	0.86	0.97	-0.42	-0.44	0.36	0.84	0.26	0.01	-0.08		0.43	0.67	-0.77	-0.99	0.93	0.96
Total Current Assets	0.93	0.64	0.26	0.74	-0.38	-0.68	-0.62	0.65	0.54	-0.32	0.64	0.54	0.5	-0.78	0.57	0.75	0.94	-0.5	0.22	0.43		0.73	-0.54	-0.44	0.63	0.63
Cash And Equivalents	0.67	0.95	0.25	0.97	-0.62	-0.85	-0.89	0.95	0.81	-0.41	0.95	0.81	0.23	-0.37	0.22	0.88	0.52	-0.63	0.02	0.67	0.73		-0.41	-0.62	0.7	0.69
Intangible Assets	-0.66	-0.56	-0.93	-0.45	0.77	0.77	0.59	-0.54	-0.77	0.9	-0.55	-0.77	0.44	0.6	-0.53	-0.65	-0.44	-0.31	-0.47	-0.77	-0.54	-0.41		0.8	-0.82	-0.83
Common Stock	-0.66	-0.82	-0.83	-0.73	1.0	0.91	0.87	-0.81	-0.95	0.94	-0.82	-0.95	0.42	0.52	-0.47	-0.85	-0.27	-0.03	0.08	-0.99	-0.44	-0.62	0.8		-0.92	-0.97
Property Plant Equipment	0.75	0.83	0.81	0.77	-0.89	-0.89	-0.81	0.81	0.92	-0.84	0.83	0.92	-0.24	-0.5	0.35	0.82	0.53	0.01	0.08	0.93	0.63	0.7	-0.82	-0.92		0.97
Property Plant And Equipment Net	0.8	0.84	0.8	0.8	-0.94	-0.93	-0.87	0.84	0.94	-0.9	0.84	0.94	-0.24	-0.63	0.5	0.89	0.5	-0.05	-0.02	0.96	0.63	0.69	-0.83	-0.97	0.97

Click cells to compare fundamentals

Organon Account Relationship Matchups

Organon fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.5B	10.4B	10.7B	11.0B	12.1B	11.9B
Short Long Term Debt Total	104M	31M	9.1B	8.9B	8.8B	4.9B
Other Current Liab	1.0B	2.3B	1.0B	1.2B	1.4B	1.3B
Total Current Liabilities	1.3B	1.2B	2.6B	2.5B	2.9B	2.2B
Total Stockholder Equity	7.0B	(820M)	(1.5B)	(892M)	(70M)	(66.5M)
Other Liab	2.0B	1.9B	283M	280M	252M	239.4M
Net Tangible Assets	1.9B	380M	(6.9B)	(6.1B)	(5.5B)	(5.3B)
Accounts Payable	258M	259M	1.4B	1.1B	1.3B	849.6M
Cash	319M	500M	737M	706M	693M	586.5M
Other Assets	659M	347M	464M	539M	485.1M	435.7M
Long Term Debt	70M	0.0	9.1B	8.9B	8.8B	4.9B
Cash And Short Term Investments	319M	500M	737M	706M	693M	586.5M
Net Receivables	1.5B	1.1B	1.4B	1.5B	1.7B	1.6B
Long Term Debt Total	70M	0.0	9.1B	8.9B	10.2B	10.8B
Liabilities And Stockholders Equity	10.5B	10.4B	10.7B	11.0B	12.1B	11.9B
Inventory	1.1B	913M	915M	1.0B	1.3B	1.1B
Other Current Assets	1.1B	1.6B	726M	747M	756M	764M
Other Stockholder Equity	7.9B	216M	(513M)	(564M)	25M	23.8M
Total Liab	3.5B	11.3B	12.2B	11.8B	12.1B	10.1B
Total Current Assets	4.0B	3.4B	3.8B	3.9B	4.5B	4.3B
Cash And Equivalents	319M	12M	737M	706M	811.9M	444.0M
Intangible Assets	569M	503M	651M	649M	533M	495.6M
Property Plant Equipment	762M	1.1B	973M	1.2B	1.4B	1.0B

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving together with Organon Stock

0.76	ME	23Andme Holding	Pair Corr
0.92	VALN	Valneva SE ADR Downward Rally	Pair Corr
0.72	VCNX	Vaccinex	Pair Corr

Moving against Organon Stock

0.89	BMY	Bristol Myers Squibb	Pair Corr
0.88	GILD	Gilead Sciences	Pair Corr
0.85	EWTX	Edgewise Therapeutics	Pair Corr
0.69	VRDN	Viridian Therapeutics	Pair Corr
0.64	KZR	Kezar Life Sciences	Pair Corr

The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.

The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:

How To Invest In Organon

Details

Is Organon Stock a good investment?

Details

What is Organon's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

5.081

Dividend Share

1.12

Earnings Share

5.05

Revenue Per Share

24.984

Quarterly Revenue Growth

0.041

The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Organon Other Current Assets vs Accounts Payable Analysis

Other Current Assets vs Accounts Payable

Other Current Assets vs Accounts Payable Correlation Analysis

Correlation Coefficient

Other Current Assets

Accounts Payable

Organon fundamental ratios Correlations

Organon Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Organon fundamental ratios Accounts

Pair Trading with Organon

Moving together with Organon Stock

Moving against Organon Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Common Stock	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Accounts Payable	+ 0.99	Short Long Term Debt Total
Long Term Debt	+ 0.99	Accounts Payable
Total Current Liabilities	+ 0.97	Short Long Term Debt Total

Common Stock	- 0.99	Total Liab
Total Liab	- 0.99	Total Stockholder Equity
Long Term Debt Total	- 0.98	Net Tangible Assets
Long Term Debt	- 0.98	Net Tangible Assets
Long Term Debt Total	- 0.98	Other Liab
Net Tangible Assets	- 0.98	Short Long Term Debt Total